Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX
Authors:
- Jordan M. WinterJWJordan M. Winter
- Steven C. CunninghamSCSteven C. Cunningham
- Saeed R. KahnSKSaeed R. Kahn
- Scott E. KernSKScott E. Kern
Open Access
- 19 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 26 (10) , 1811-1820
Abstract
Norethindrone is a commonly used drug for contraception and hormone replacement therapy, whose carcinogenic potential is still controversial. We applied a novel and particularly sensitive method to screen for DNA damage with special attention to double-strand breaks (DSBs) and identified norethindrone to be likely genotoxic and therefore potentially mutagenic: a p53-reporter assay served as a first, high-throughput screening method and was followed by the immunofluorescent detection of phosphorylated H2AX as a sensitive assay for the presence of DSBs. Norethindrone at concentrations of 2–100 μg/ml activated p53 and phosphorylated H2AX specifically and in a dose-dependent manner. No p53 activation or H2AX phosphorylation was detected using a panel of structurally/functionally related drugs. The overall amount of DNA damage induced by norethindrone was low as compared with etoposide and ionizing radiation. Consistently, norethindrone treatment did not cause a cell cycle arrest. DSBs were not detected with the neutral comet assay, a less sensitive method for DSB assessment than H2AX phosphorylation. Our findings in the p53-reporter and γ-H2AX assays could not be ascribed to common DSB-causing artifacts in standard genotoxicity screening, including drug precipitation, high cytotoxicity levels and increased apoptosis. Therefore, our study suggests that norethindrone induces DSBs in our experimental setting, both complementing and adding a new aspect to the existing literature on the genotoxic potential of norethindrone. As the effective concentrations of norethindrone used in our assays were ∼100- to 1000-fold higher than therapeutical doses, the significance of these findings with regard to human exposure still remains to be determined.Keywords
This publication has 35 references indexed in Scilit:
- Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell LinesCancer Research, 2004
- H2AX: the histone guardian of the genomeDNA Repair, 2004
- p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing.Environmental Health Perspectives, 1999
- Single cell gel electrophoresis: Detection of DNA damage at different levels of sensitivityElectrophoresis, 1999
- A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damageCarcinogenesis, 1998
- On the Role of DNA Double-Strand Breaks in Toxicity and CarcinogenesisCritical Reviews in Toxicology, 1997
- Multilaboratory comparison of in vitro tests for chromosome aberrations in CHO and CHL cells tested under the same protocolsEnvironmental and Molecular Mutagenesis, 1997
- DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.Molecular and Cellular Biology, 1994
- A comparison of chromosome aberration induction by 25 compounds tested by two Chinese hamster cell (CHL and CHO) systems in cultureMutation Research/Genetic Toxicology, 1990
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988